OrthoGrid Systems receives FDA clearance for new orthopedic distortion adaptation technology

The FDA granted OrthoGrid Systems’ PhantomMSK Orthopedic Platform 510(k) clearance.

Advertisement

Three things to know:

1. As a result of the FDA clearance, OrthoGrid plans to launch a national educational campaign about the importance of recognizing and correcting for fluoroscopic distortion for physicians performing orthopedic surgery.

“Fluoroscopy is utilized in most direct anterior approach hip arthroplasty procedures, as it reveals real-time implant position and anatomic landmarks. But until now, there has been virtually no method to correct the highly variable distortion present in all fluoroscopic X-rays due to electromagnetic interference,” said orthopedic surgeon John Masonis, MD. 

2. Its PhantomMSK System is designed to assist in direct anterior approach total hip arthroplasty surgery, where it is intended to help restore native hip biomechanics with alignment considerations for leg length, femoral offset, cup inclination, femoral abduction, pelvic tilt and pelvic obliquity.

3. OrthoGrid is an intraoperative imaging technology company focused on orthopedics.

More articles on devices:
Abrazo Medical Group installs Mazor Robotics’ Renaissance Guidance System — 3 insights
Activ Surgical names Todd Usen CEO — 3 insights
MedShape launches bone fixation system — 4 insights

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.